← 返回临床试验

CAR-T 治疗、单次异基因造血干细胞移植或化疗后儿童远程认知训练与正念干预

英文原题:Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

查看英文原题

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

ClinicalTrials.gov 2026/03/18(首次登记) 注册临床试验(分期未标注) · 招募中

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

简要介绍

这是一项分期未标注的注册临床试验,评估细胞治疗用于急性淋巴细胞白血病的安全性、可行性及初步疗效。当前状态:招募中。计划入组 40 例。试验地点:欧洲 · 马德里(共 1 个中心)。登记号:NCT07479927。

入组条件决定能不能参加

不限性别 · ≥ 8 Years 且 ≤ 18 Years

纳入标准:确诊B细胞急性淋巴细胞白血病;既往接受CAR-T 治疗、化疗和/或造血干细胞移植;年龄8–18岁;西班牙语为母语或熟练掌握西班牙语,足以理解研究流程并完成评估工具;可使用联网电脑、平板或智能手机。

排除标准:确诊智力障碍、自闭症谱系障碍或获得性脑损伤;存在与白血病无关且未控制或不稳定的躯体或精神疾病。
核对登记原文(英文)
Inclusion Criteria:

* Diagnosis of acute B-cell lymphoblastic leukemia.
* Previous treatment with CAR-T therapy, chemotherapy, and/or hematopoietic stem cell transplantation.
* Age between 8 and 18 years.
* Native Spanish speaker or high proficiency in Spanish sufficient to understand study procedures and complete assessment instruments.
* Access to a computer, tablet, or smartphone with an Internet connection.

Exclusion Criteria:

* Diagnosis of intellectual disability, autism spectrum disorder, or acquired brain injury.
* Presence of uncontrolled or unstable medical or psychiatric conditions unrelated to leukemia.

以上为辅助阅读译文。是否适合入组须由主治医生判断,最终以登记平台与研究者确认为准。

研究终点衡量什么算有效

  • 主要终点符号数字模式测验(SDMT)基线
  • 主要终点连续操作测验第三版(CPT-3)基线
  • 主要终点记忆临床评估(ECM)基线
  • 主要终点言语流畅性测验(VFT)基线
  • 主要终点Stroop色词测验修订版基线
  • 主要终点符号数字模式测验(SDMT)6个月
  • 次要终点执行功能行为评定量表第二版(BRIEF-2)
  • 次要终点儿童行为评估系统第三版(BASC-3)
  • 次要终点简明疼痛量表(BPI)
  • 次要终点青少年失眠问卷(AIQ)
  • 次要终点PROMIS儿童睡眠障碍简表
  • 次要终点儿童与青少年正念量表(CAMM)
  • 次要终点脑功能连接
  • 次要终点生物标志物
核对登记原文(英文)

主要终点:Symbol Digit Modalities Test (SDMT). · It assesses processing speed based on the total number of items completed in 90 seconds. Scores range from 0 to a maximum determined by the speed of task completion. Higher scores indicate better processing speed. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · Baseline;Continuous Performance Test, third edition (CPT-3) · It assesses sustained visual attention, impulsivity, and vigilance through continuous performance tasks that require responses to target stimuli and inhibition of non-target stimuli. Outcome measures include omission errors, commission errors, reaction time, and variability, which are expressed as standardized T-scores. Higher T-scores indicate poorer performance. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · Baseline;Clinical Assessment of Memory (ECM) · It assesses working memory and immediate memory in auditory-verbal and visuospatial modalities. Scores are expressed as standardized scores based on Spanish norms. Higher scores indicate better memory performance. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · Baseline;Verbal Fluency Test (VFT) · Assesses linguistic and executive functions, including phonological and semantic fluency. The score is the total number of correct words generated in 60 seconds. Higher scores indicate better performance. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · Baseline;Stroop. Test of Colors and Words. Revised edition. · It measures attention and executive functioning, specifically the ability to inhibit automatic responses and resist interference from established behavior patterns. Scores are based on the number of correct responses completed in 45 seconds, depending on the condition. Higher scores indicate better executive functioning. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · Baseline;Symbol Digit Modalities Test (SDMT) · It assesses processing speed based on the total number of items completed in 90 seconds. Scores range from 0 to a maximum determined by the speed of task completion. Higher scores indicate better processing speed. The scores will be converted to z-scores (mean = 0; standard deviation = 1) to equate and compare the values of instruments with different units of measurement. · 6 months
次要终点:Behavior Rating Inventory of Executive Function, second edition (BRIEF-2);Behavior Assessment System for Children, third edition (BASC-3);Brief Pain Inventory (BPI);Adolescent Insomnia Questionnaire (AIQ);Pediatric Sleep Disturbances Short Form (PROMIS);Child and Adolescent Mindfulness Measure (CAMM).;Brain Functional Connectivity;Biomarkers

研究设计怎么做的

研究类型
干预性研究
入组人数
40 人(预计)
分组方式
随机分组
  • 认知训练→正念试验组

    参与者先接受数字认知训练,随后在线接受正念干预。

  • 正念→认知训练试验组

    参与者先在线接受正念干预,随后接受数字认知训练。

  • 候补名单对照无干预组

    主要研究期间参与者不接受干预;研究结束后可获得完整项目。

核对分组登记原文(英文)
  • Cognitive Training → Mindfulness · EXPERIMENTAL · Participants receive digital cognitive training followed by a mindfulness-based intervention delivered online.
  • Mindfulness → Cognitive Training · EXPERIMENTAL · Participants receive a mindfulness-based intervention delivered online followed by digital cognitive training.
  • Waitlist Control · NO_INTERVENTION · Participants do not receive the intervention during the main study period and are offered the full program after study completion.

关键日期

开始日期
2025-12-19
主要完成日期
2027-07-30
全部完成日期
2027-12-30
登记状态核实于
2026-03

联系与责任方公示信息

主要研究者
Dr. Eduardo Fernández-Jiménez
申办方
Hospital Universitario La Paz
合作方
Instituto de Investigación Hospital Universitario La Paz
联系电话
+34917277417

以上邮箱 / 电话是登记库里的申办方联系方式,通常不直达某家医院。中国中心的联系方式请以医院或登记平台最新公示为准。

登记简述

这项随机对照临床试验评估既往接受CAR-T 细胞治疗、化疗和/或造血干细胞移植(HSCT)的急性淋巴细胞白血病儿童和青少年的神经认知、生物心理学及脑连接组结局。参与者接受多模式远程心理干预,结合数字认知训练和经调整的正念情绪调节项目;研究将其与候补名单对照组比较,干预顺序采用平衡设计:认知训练后接正念,或正念后接认知训练。在基线、干预后及6个月随访时评估神经认知表现、情绪行为、执行功能及基于脑电图的功能连接。

核对登记原文(英文)

This randomized controlled clinical trial evaluates neurocognitive, biopsychological, and brain connectome outcomes in children and adolescents with acute lymphoblastic leukemia who have previously received Chimeric Antigen Receptor T-cell therapy (CAR T-cell therapy), chemotherapy, and/or hematopoietic stem cell transplantation (HSCT). Participants will receive a multimodal, telematic psychological intervention combining digital cognitive training and an adapted mindfulness-based emotional regulation program. Outcomes will be compared with a waitlist control group and intervention sequences will be counterbalanced: (1) cognitive training followed by mindfulness; and (2) mindfulness followed by cognitive training. Neurocognitive performance, emotional-behavioral functioning, executive functioning and EEG-based functional connectivity will be assessed at baseline, post-intervention and at 6 months follow-up.

登记原文与核验信息

试验登记号
NCT07479927
试验期别
NA
试验状态
招募中
试验中心(1 个)
西班牙 1
适应症(原文)
Acute Lymphoblastic Leukemia
干预方式(原文)
Digital cognitive training; Online Mindfulness-Based Intervention